Relationship Between the Apheresis Center and the Cell Therapy Developer
The relationship between the apheresis center and cell therapy developer/provider An outstanding article from Suzanne Kamps of Adaptimmune in Cell & Gene Therapy Insights on the growing importance of the relationship between the apheresis center and cell therapy developer/provider. “…clearly communicating our (Adaptimmune) message about our specific treatment and allowing apheresis centers the autonomy to […]
New York Blood Center Unveils $50 Million Investment Fund
New York Blood Center Unveils NYBC Ventures Blood Centers of America member, New York Blood Center, unveils its $50 million investment fund called NYBC Ventures. This newly formed investment fund focusses on blood and cellular therapeutics. The financing for this new venture is tied to proceeds from solvent detergent plasma processes, patented by NYBC. Since […]
2023 Cell Therapy Accomplishments So Far
Cell therapies made significant improvements in Q1 2023 Thus far in 2023: One cell therapy BLA approved by the FDA (1st expanded hematopoietic stem cell product, 1st manufactured umbilical cord blood services product). Four advanced therapies BLA submissions: First Iovance (1st TIL cell therapy), Next, Adaptimmune (1st engineered TCR cell therapy), Then, 1st BLA submission […]
LifeSouth Community Blood Centers Selected to Provide Umbilical Cord Blood-Derrived CD34 Cells for ISS Mission
Blood Centers of America member, LifeSouth Community Blood Centers, selected to provide CD34 cells to Dr. Abba C. Zubair of Mayo Clinic. Blood Centers of America member LifeSouth Community Blood Centers, headquartered in Gainesville, Fla., was selected to provide umbilical cord blood-derived CD34 cells to regenerative medicine specialist Dr. Abba C. Zubair of Mayo Clinic […]
Cord Blood Connect Calls for Abstracts
Cord Blood Connect calls for abstracts to publish in STEM CELLS Translational Medicine. Whether your work focuses on preclinical studies, clinical trials, perinatal tissue banking and therapies, cord blood collection, or cord blood bank management, your work is impactful to the cord blood community. Submit your abstract for consideration by June 16, 2023. Learn more […]
Challenges and Future Opportunities for CAR-T
An interview of Dr. Michael Tees and Dr. Fred Locke offering clinician views on CAR-T A great interview of Dr. Michael Tees and Dr. Fred Locke by Arsalan Arif offering clinician views on current challenges and future opportunities for CAR-T (autologous + allogeneic). Link to video: https://carttogether.com Our takeaways? (1) There’s a move toward outpatient […]
Iovance Biotherapeutics Completes their BLA Submission for Lifileucel
An autologous tumor-infiltrating lymphocyte therapy for the treatment of advanced melanoma.
Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), and Blood Centers of America (BCA) today announced that they have executed a collaborative agreement to develop commercial relationships to serve unmet needs by utilizing the Symphony Platform in the blood and hospital markets.